Ellen G. Chadwick, MD

Clinical and Community Trials

Research Interests

  • HIV
  • AIDS
  • Antiretroviral Therapy
  • HIV-infected Infants

Biography

  • Director, Section of Pediatric, Adolescent, and Maternal HIV Infection, Ann & Robert H. Lurie Children's Hospital of Chicago
  • Attending Physician, Infectious Diseases, Ann & Robert H. Lurie Children's Hospital of Chicago
  • Susan B. DePree Founders' Board Professorship in Pediatric, Adolescent and Maternal HIV Infection, Ann & Robert H. Lurie Children's Hospital of Chicago
  • Professor of Pediatrics (Infectious Diseases), Northwestern University Feinberg School of Medicine

See Lurie Children's Provider Profile

Education and Background

  • Fellowship in Pediatric Infectious Diseases, Children's Memorial Hospital 1982-1985
  • Residency in Pediatrics, Children's Memorial Hospital 1979-1982
  • MD, University of Virginia School of Medicine 1979

Clinical Studies

Recruiting

Very Early Intensive Treatment of HIV-Infected Infants to Achieve HIV Remission

The Pharmacokinetics, Safety, and Tolerability of Abacavir/Dolutegravir/Lamivudine Dispersible and Immediate Release Tablets in HIV-1-Infected Children Less Than 12 Years of Age

Recruiting

Surveillance Monitoring for ART Toxicities Study in HIV Uninfected Children Born to HIV Infected Women

Recruiting

Study of Tecovirimat for Human Monkeypox Virus

Recruiting

Safety and Immunogenicity of a Single Dose of the Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV ΔNS2/Δ1313/I1314L, RSV 6120/ΔNS2/1030s, RSV 276 or Placebo, Delivered as Nose Drops to RSV-Seronegative Children 6 to 24 Mont

Recruiting

Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum

Recruiting

More Options for Children and Adolescents (MOCHA): Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in HIV-Infected Children and Adolescents

Evaluating the Infectivity, Safety, and Immunogenicity of Recombinant Live-Attenuated RSV Vaccines RSV ΔNS2/Δ1313/I1314L or RSV 276 in RSV-Seronegative Infants 6 to 24 Months of Age

Publications

Jan. 30, 2024

Factors associated with internalized HIV-related stigma among biological mothers living with HIV enrolled in a US cohort study.

Dec. 04, 2023

HIV-1 reservoir size after neonatal antiretroviral therapy and the potential to evaluate antiretroviral-therapy-free remission (IMPAACT P1115): a phase 1/2 proof-of-concept study.

Nov. 01, 2023

The role of internalised HIV stigma in disclosure of maternal HIV serostatus to children perinatally HIV-exposed but uninfected: a prospective study in the United States.

See all publications

Similar Researchers

Clinical and Community Trials

Debra E. Weese-Mayer, MD

Research Interests

Autonomic medicine, Circadian rhythms, Developmental neurobiology, Developmental genetics, Endocrine genetics, Pacemakers, Respiratory diseases, Sudden cardiac death

Recent Publication

Computer-aided diagnostic screen for Congenital Central Hypoventilation Syndrome with facial phenotype.

Jan. 18, 2024
Basic and Preclinical Science

Patrick C. Seed, MD, PhD, FIDSA

Seed Laboratory

Research Interests

Microbiome, Host-microbial interactions, Infectious diseases, Molecular pathogenesis

Recent Publication

Gut microbiota analyses of cutaneous T-cell lymphoma patients undergoing narrowband ultraviolet B therapy reveal alterations associated with disease treatment.

Jan. 11, 2024
Basic and Preclinical Science

Anne H. Rowley, MD

Principal Investigator

Rowley Laboratory

Research Interests

Kawasaki Disease, Antibody Responses to Infectious Diseases

Recent Publication

Analysis of Plasmablasts from Children with Kawasaki Disease Reveals Evidence of a Convergent Antibody Response to a Specific Protein Epitope.

Feb. 22, 2023
Clinical and Community Trials

Jennifer Jao, MD, MPH

Research Interests

HIV/AIDS, Maternal-Child HIV, Pregnancy, Metabolic Complications of HIV and its Treatment, Women’s Health, Pediatric, Adolescent HIV

Recent Publication

Measurement of body composition in postpartum South African women living with and without HIV infection.

Feb. 07, 2024
Basic and Preclinical Science

Isabelle De Plaen, MD

Principal Investigator

De Plaen Laboratory

Research Interests

Cytokines, Digestive System (Including Gallbladder and Liver), Immunology, Necrotizing Enterocolitis, Neonatal Necrotizing Entercolitis

Recent Publication

Recombinant IGF-1/BP3 protects against intestinal injury in a neonatal mouse NEC model.

Feb. 28, 2024
Clinical and Community Trials

Jenna E. Rossoff, MD

Research Interests

Pediatric Oncology, Leukemia, Infectious Complications of Cancer Therapy

Recent Publication

Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer.

Dec. 07, 2023